• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同源重组所需核酸酶之间的冗余促进了真核模式生物盘基网柄菌对PARP抑制剂的抗性。

Redundancy between nucleases required for homologous recombination promotes PARP inhibitor resistance in the eukaryotic model organism Dictyostelium.

作者信息

Kolb Anna-Lena, Gunn Alasdair R, Lakin Nicholas D

机构信息

Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.

出版信息

Nucleic Acids Res. 2017 Sep 29;45(17):10056-10067. doi: 10.1093/nar/gkx639.

DOI:10.1093/nar/gkx639
PMID:28973445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5622368/
Abstract

ADP-ribosyltransferases promote repair of DNA single strand breaks and disruption of this pathway by Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) is toxic to cells with defects in homologous recombination (HR). Here, we show that this relationship is conserved in the simple eukaryote Dictyostelium and exploit this organism to define mechanisms that drive resistance of the HR-deficient cells to PARPi. Dictyostelium cells disrupted in exonuclease I, a critical factor for HR, are sensitive to PARPi. Deletion of exo1 prevents the accumulation of Rad51 in chromatin induced by PARPi, resulting in DNA damage being channelled through repair by non-homologous end-joining (NHEJ). Inactivation of NHEJ supresses the sensitivity of exo1- cells to PARPi, indicating this pathway drives synthetic lethality and that in its absence alternative repair mechanisms promote cell survival. This resistance is independent of alternate-NHEJ and is instead achieved by re-activation of HR. Moreover, inhibitors of Mre11 restore sensitivity of dnapkcs-exo1- cells to PARPi, indicating redundancy between nucleases that initiate HR can drive PARPi resistance. These data inform on mechanism of PARPi resistance in HR-deficient cells and present Dictyostelium as a convenient genetic model to characterize these pathways.

摘要

ADP-核糖基转移酶促进DNA单链断裂的修复,而聚(ADP-核糖)聚合酶(PARP)抑制剂(PARPi)对这一途径的破坏对同源重组(HR)存在缺陷的细胞具有毒性。在此,我们表明这种关系在简单真核生物盘基网柄菌中是保守的,并利用这种生物体来确定驱动HR缺陷细胞对PARPi产生抗性的机制。在核酸外切酶I(HR的关键因子)中被破坏的盘基网柄菌细胞对PARPi敏感。exo1的缺失阻止了PARPi诱导的Rad51在染色质中的积累,导致DNA损伤通过非同源末端连接(NHEJ)进行修复。NHEJ的失活抑制了exo1 -细胞对PARPi的敏感性,表明该途径驱动合成致死性,并且在其不存在时,替代修复机制促进细胞存活。这种抗性独立于替代NHEJ,而是通过HR的重新激活来实现的。此外,Mre11抑制剂恢复了dnapkcs - exo1 -细胞对PARPi的敏感性,表明启动HR的核酸酶之间的冗余可以驱动PARPi抗性。这些数据揭示了HR缺陷细胞中PARPi抗性的机制,并将盘基网柄菌作为一种方便的遗传模型来表征这些途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/2c21458faab7/gkx639fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/794dda5db21c/gkx639fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/61cc50839fe2/gkx639fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/278956776340/gkx639fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/f5c99ddb1fda/gkx639fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/2c21458faab7/gkx639fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/794dda5db21c/gkx639fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/61cc50839fe2/gkx639fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/278956776340/gkx639fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/f5c99ddb1fda/gkx639fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3cf/5622368/2c21458faab7/gkx639fig5.jpg

相似文献

1
Redundancy between nucleases required for homologous recombination promotes PARP inhibitor resistance in the eukaryotic model organism Dictyostelium.同源重组所需核酸酶之间的冗余促进了真核模式生物盘基网柄菌对PARP抑制剂的抗性。
Nucleic Acids Res. 2017 Sep 29;45(17):10056-10067. doi: 10.1093/nar/gkx639.
2
Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair.类蓬松蛋白激酶缺失通过阻碍非同源末端连接修复,使BRCA1突变型癌症产生PARP抑制剂抗性。
Mol Med. 2025 Jan 22;31(1):18. doi: 10.1186/s10020-025-01066-z.
3
Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.药物驱动的合成致死性:联合使用AsiDNA和PARP抑制剂绕过肿瘤细胞遗传学
Clin Cancer Res. 2017 Feb 15;23(4):1001-1011. doi: 10.1158/1078-0432.CCR-16-1193. Epub 2016 Aug 24.
4
Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.染色质解旋酶 DNA 结合蛋白 4(CHD4)调节同源重组 DNA 修复,其缺乏使细胞对聚(ADP-核糖)聚合酶(PARP)抑制剂治疗敏感。
J Biol Chem. 2012 Feb 24;287(9):6764-72. doi: 10.1074/jbc.M111.287037. Epub 2012 Jan 4.
5
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.ALC1 将染色质可及性与同源重组缺陷细胞中 PARP 抑制剂的反应联系起来。
Nat Cell Biol. 2021 Feb;23(2):160-171. doi: 10.1038/s41556-020-00624-3. Epub 2021 Jan 18.
6
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.普雷沙替尼治疗诱导同源重组缺陷,并与奥拉帕利在三阴性乳腺癌细胞中协同作用。
Breast Cancer Res. 2019 Sep 6;21(1):104. doi: 10.1186/s13058-019-1192-2.
7
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.组蛋白甲基转移酶 EHMT1 和 EHMT2(GLP/G9A)维持高级别浆液性卵巢癌对聚腺苷二磷酸核糖聚合酶抑制剂的耐药性。
Clin Epigenetics. 2019 Nov 27;11(1):165. doi: 10.1186/s13148-019-0758-2.
8
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.Wnt 信号激活促进奥拉帕利耐药卵巢癌。
Mol Carcinog. 2019 Oct;58(10):1770-1782. doi: 10.1002/mc.23064. Epub 2019 Jun 10.
9
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.BET 抑制剂 INCB054329 降低卵巢癌细胞中同源重组效率并增强 PARP 抑制剂的活性。
Gynecol Oncol. 2018 Jun;149(3):575-584. doi: 10.1016/j.ygyno.2018.03.049. Epub 2018 Mar 20.
10
Combined effects of carbon ion radiation and PARP inhibitor on non-small cell lung carcinoma cells: Insights into DNA repair pathways and cell death mechanisms.碳离子辐射与PARP抑制剂对非小细胞肺癌细胞的联合作用:对DNA修复途径和细胞死亡机制的见解
DNA Repair (Amst). 2024 Dec;144:103778. doi: 10.1016/j.dnarep.2024.103778. Epub 2024 Oct 19.

引用本文的文献

1
Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones.通过组蛋白丝氨酸 ADP-核糖基化将 DNA 修复与细胞周期进程联系起来。
Nat Commun. 2022 Jan 13;13(1):185. doi: 10.1038/s41467-021-27867-4.
2
as a Model to Assess Genome Stability Through DNA Repair.作为一种通过DNA修复评估基因组稳定性的模型。
Front Cell Dev Biol. 2021 Oct 7;9:752175. doi: 10.3389/fcell.2021.752175. eCollection 2021.

本文引用的文献

1
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.诱杀癌细胞:PARP 抑制剂及其作用机制。
Sci Transl Med. 2016 Oct 26;8(362):362ps17. doi: 10.1126/scitranslmed.aaf9246.
2
The role of ADP-ribosylation in regulating DNA interstrand crosslink repair.ADP核糖基化在调节DNA链间交联修复中的作用。
J Cell Sci. 2016 Oct 15;129(20):3845-3858. doi: 10.1242/jcs.193375. Epub 2016 Sep 1.
3
PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
聚(ADP-核糖)聚合酶1(PARP1)将CHD2介导的染色质扩张和H3.3沉积与非同源末端连接的DNA修复联系起来。
Mol Cell. 2016 Feb 18;61(4):547-562. doi: 10.1016/j.molcel.2016.01.019.
4
Targeting the DNA Damage Response in Cancer.靶向癌症的 DNA 损伤反应。
Mol Cell. 2015 Nov 19;60(4):547-60. doi: 10.1016/j.molcel.2015.10.040.
5
REV7 counteracts DNA double-strand break resection and affects PARP inhibition.REV7可对抗DNA双链断裂切除并影响聚(ADP-核糖)聚合酶抑制作用。
Nature. 2015 May 28;521(7553):541-544. doi: 10.1038/nature14328. Epub 2015 Mar 23.
6
A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stress.单 ADP 核糖基转移酶 PARP14/ARTD8 在促进同源重组和抵御复制应激中的新作用。
Nucleic Acids Res. 2015 Mar 31;43(6):3143-53. doi: 10.1093/nar/gkv147. Epub 2015 Mar 9.
7
Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.同源重组缺陷型肿瘤依赖于 Polθ 介导的修复。
Nature. 2015 Feb 12;518(7538):258-62. doi: 10.1038/nature14184. Epub 2015 Feb 2.
8
Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination.哺乳类聚合酶θ促进替代性非同源末端连接和抑制重组。
Nature. 2015 Feb 12;518(7538):254-7. doi: 10.1038/nature14157. Epub 2015 Feb 2.
9
Family-wide analysis of poly(ADP-ribose) polymerase activity.聚(ADP - 核糖)聚合酶活性的全家族分析。
Nat Commun. 2014 Jul 21;5:4426. doi: 10.1038/ncomms5426.
10
The ADP-ribosyltransferase PARP10/ARTD10 interacts with proliferating cell nuclear antigen (PCNA) and is required for DNA damage tolerance.ADP-核糖基转移酶 PARP10/ARTD10 与增殖细胞核抗原 (PCNA) 相互作用,是 DNA 损伤耐受所必需的。
J Biol Chem. 2014 May 9;289(19):13627-37. doi: 10.1074/jbc.M114.556340. Epub 2014 Apr 2.